Tag: TGen

michael j demeure md1

Carcinoid Cancer Foundation Presents Symposium on Cutting-Edge Treatment

March 23, 2010

Determining Molecular Signature:  A Guide for Targeted Therapy of Neuroendocrine Tumors

Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis.  This is the cutting-edge…

READ MORE
stevejobs ca

Steve Jobs, Pancreatic Neuroendocrine Tumor Patient, Talks about Liver Transplant

March 21, 2010

Steve Jobs, CEO of Apple, is the most well-known member of the carcinoid and neuroendocrine tumor community. He was diagnosed with an islet cell pancreatic neuroendocrine tumor (NET) in 2004 for which he had surgery, followed by a liver transplant in …

READ MORE